ZA977745B - Transdermal delivery of peptides - Google Patents
Transdermal delivery of peptidesInfo
- Publication number
- ZA977745B ZA977745B ZA977745A ZA977745A ZA977745B ZA 977745 B ZA977745 B ZA 977745B ZA 977745 A ZA977745 A ZA 977745A ZA 977745 A ZA977745 A ZA 977745A ZA 977745 B ZA977745 B ZA 977745B
- Authority
- ZA
- South Africa
- Prior art keywords
- peptides
- transdermal delivery
- transdermal
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK90996 | 1996-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA977745B true ZA977745B (en) | 1998-08-11 |
Family
ID=8098895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA977745A ZA977745B (en) | 1996-08-29 | 1997-08-28 | Transdermal delivery of peptides |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3938797A (en) |
WO (1) | WO1998008492A1 (en) |
ZA (1) | ZA977745B (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2205692A1 (en) * | 1997-05-16 | 1998-11-16 | Hyal Pharmaceutical Corporation | Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation |
US5882677A (en) * | 1997-09-30 | 1999-03-16 | Becton Dickinson And Company | Iontophoretic patch with hydrogel reservoir |
US6039977A (en) * | 1997-12-09 | 2000-03-21 | Alza Corporation | Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods |
US8133505B2 (en) | 2002-10-31 | 2012-03-13 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
US7383084B2 (en) | 2002-10-31 | 2008-06-03 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
IL152574A (en) | 2002-10-31 | 2009-09-22 | Transpharma Medical Ltd | Transdermal delivery system for dried particulate or lyophilized medications |
US7662404B2 (en) | 2002-10-31 | 2010-02-16 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides |
US8420605B2 (en) * | 2005-09-07 | 2013-04-16 | The University Of Strathclyde | Hydrogel compositions |
KR20080066712A (en) * | 2005-09-30 | 2008-07-16 | 티티아이 엘뷰 가부시키가이샤 | Functionalized microneedles transdermal drug delivery systems, devices, and methods |
JP2010502270A (en) * | 2006-08-29 | 2010-01-28 | アルザ・コーポレーシヨン | Chemical electrotransport with hydration measurements in hydratable reservoirs |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
RU2500685C2 (en) | 2006-11-10 | 2013-12-10 | Кара Терапеутикс, Инк | Synthetic peptide amides |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
CA2710039C (en) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer |
EP3023426A1 (en) | 2008-07-17 | 2016-05-25 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
US10342830B2 (en) | 2015-01-05 | 2019-07-09 | Gary M. Petrucci | Methods and materials for treating lung disorders |
US10993969B2 (en) | 2016-02-05 | 2021-05-04 | Gary M. Petrucci | Methods and materials for treating nerve injuries and neurological disorders |
US10478531B2 (en) | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ277486A (en) * | 1993-12-23 | 1997-03-24 | Novo Nordisk As | Synthetic peptides with growth hormone releasing properties |
HUP9802821A3 (en) * | 1995-06-22 | 2000-03-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
-
1997
- 1997-08-26 AU AU39387/97A patent/AU3938797A/en not_active Abandoned
- 1997-08-26 WO PCT/DK1997/000346 patent/WO1998008492A1/en active Application Filing
- 1997-08-28 ZA ZA977745A patent/ZA977745B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU3938797A (en) | 1998-03-19 |
WO1998008492A1 (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA977745B (en) | Transdermal delivery of peptides | |
IL120943A0 (en) | Transdermal delivery system | |
AUPO066096A0 (en) | Oral delivery of peptides | |
HUP0000522A3 (en) | N-acyl phoshpatidylethanolamine-mediated liposomal drug delivery | |
EP0941120A4 (en) | Branched peptide linkers | |
IL123258A0 (en) | Opioid peptides | |
IL127332A0 (en) | Peptide derivatives | |
EP0941039A4 (en) | Transdermal administration of ment | |
GB9702377D0 (en) | Peptide derivatives | |
PL339085A1 (en) | Recombinative expression of insulin peptide c | |
GB9718110D0 (en) | Peptides | |
GB9714276D0 (en) | Peptides and related compounds | |
GB9700154D0 (en) | Peptides | |
EP0996457A4 (en) | Fsh-releasing peptides | |
EP0935608A4 (en) | Cytotoxic peptides | |
IL127565A0 (en) | Virginiamycin mixture | |
GB9606272D0 (en) | Gene and peptides | |
IL113441A0 (en) | Opioid peptide analoog | |
GB9618673D0 (en) | The use of muramyl peptides | |
GB9613705D0 (en) | Novel peptides | |
AU2944197A (en) | Oral delivery of peptides | |
GB9626362D0 (en) | Peptides | |
GB9612648D0 (en) | Peptides | |
SG55039A1 (en) | Peptides | |
GB9625227D0 (en) | Peptides |